"Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Central Nervous System (CNS) Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Central Nervous System (CNS) Cancer. Central Nervous System (CNS) Cancer - Pipeline Review, Half Year is built using data and information sourced...
View full press release